Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combined Treatment of Resistant Hypertension and Atrial Fibrillation

This study has been completed.
Information provided by (Responsible Party):
Meshalkin Research Institute of Pathology of Circulation Identifier:
First received: April 30, 2010
Last updated: July 8, 2013
Last verified: July 2013